(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

C53H69N5O12 — CID 89273705

IUPAC(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
SMILESCCC1=C(CC)c2nc1cc1[nH]c(c(CC)c1CC)c(-c1ccc(O[C@@H]3O[C@H](CO)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)c(O)c1)c1[nH]c(cc3nc(n2)C(CC)=C3CC)c(CC)c1CC
InChIInChI=1S/C53H69N5O12/c1-9-25-29(13-5)42-41(24-17-18-38(37(61)19-24)67-52-48(66)46(64)49(40(23-60)69-52)70-53-47(65)45(63)44(62)39(22-59)68-53)43-30(14-6)26(10-2)34(55-43)21-36-28(12-4)32(16-8)51(57-36)58-50-31(15-7)27(11-3)35(56-50)20-33(25)54-42/h17-21,39-40,44-49,52-55,59-66H,9-16,22-23H2,1-8H3/b33-20-,34-21-,35-20-,36-21-,42-41-,43-41-,58-50-,58-51-/t39-,40-,44+,45+,46-,47-,48-,49+,52-,53+/m1/s1
InChIKeyMSSRMZMOBUBPCZ-QJHLOGPUSA-N
MW968.16 g/mol
LogP5.80
Rot. Bonds15

About (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol (PubChem CID 89273705) has the molecular formula C53H69N5O12 and a molecular weight of 968.16 g/mol. Its IUPAC name is (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol.

Molecular Properties

Compound Name(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
PubChem CID89273705
Molecular FormulaC53H69N5O12
Molecular Weight968.16 g/mol
Exact Mass967.49
IUPAC Name(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
SMILESCCC1=C(CC)c2nc1cc1[nH]c(c(CC)c1CC)c(-c1ccc(O[C@@H]3O[C@H](CO)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)c(O)c1)c1[nH]c(cc3nc(n2)C(CC)=C3CC)c(CC)c1CC
InChIInChI=1S/C53H69N5O12/c1-9-25-29(13-5)42-41(24-17-18-38(37(61)19-24)67-52-48(66)46(64)49(40(23-60)69-52)70-53-47(65)45(63)44(62)39(22-59)68-53)43-30(14-6)26(10-2)34(55-43)21-36-28(12-4)32(16-8)51(57-36)58-50-31(15-7)27(11-3)35(56-50)20-33(25)54-42/h17-21,39-40,44-49,52-55,59-66H,9-16,22-23H2,1-8H3/b33-20-,34-21-,35-20-,36-21-,42-41-,43-41-,58-50-,58-51-/t39-,40-,44+,45+,46-,47-,48-,49+,52-,53+/m1/s1
InChIKeyMSSRMZMOBUBPCZ-QJHLOGPUSA-N
XLogP5.80
TPSA269.01 Ų
H-Bond Donors10
H-Bond Acceptors15
Rotatable Bonds15
Heavy Atoms70
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500968.16
LogP ≤ 55.80
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1015

Analyze (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol?
The IUPAC name of (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol (CID 89273705) is (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol.
What is the SMILES notation for (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol?
The canonical SMILES for (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol is CCC1=C(CC)c2nc1cc1[nH]c(c(CC)c1CC)c(-c1ccc(O[C@@H]3O[C@H](CO)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)c(O)c1)c1[nH]c(cc3nc(n2)C(CC)=C3CC)c(CC)c1CC.
What is the InChIKey of (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol?
The InChIKey is MSSRMZMOBUBPCZ-QJHLOGPUSA-N. The full InChI is InChI=1S/C53H69N5O12/c1-9-25-29(13-5)42-41(24-17-18-38(37(61)19-24)67-52-48(66)46(64)49(40(23-60)69-52)70-53-47(65)45(63)44(62)39(22-59)68-53)43-30(14-6)26(10-2)34(55-43)21-36-28(12-4)32(16-8)51(57-36)58-50-31(15-7)27(11-3)35(56-50)20-33(25)54-42/h17-21,39-40,44-49,52-55,59-66H,9-16,22-23H2,1-8H3/b33-20-,34-21-,35-20-,36-21-,42-41-,43-41-,58-50-,58-51-/t39-,40-,44+,45+,46-,47-,48-,49+,52-,53+/m1/s1.
What are the key properties of (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol?
(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol has a molecular weight of 968.16 g/mol, XLogP of 5.80, 15 rotatable bonds, 10 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-hydroxy-4-(4,5,9,10,14,15,19,20-octaethyl-2,21,22,23,24-pentazapentacyclo[16.2.1.13,6.18,11.113,16]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-12-yl)phenoxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol is sourced from PubChem (CID 89273705), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).